# Enhao Gong

> Enhao Gong is the CEO and co-founder of Subtle Medical, a Stanford-born AI healthcare company that has earned 9 FDA clearances for deep learning-powered medical imaging products. A PhD graduate from Stanford in Electrical Engineering, Gong co-founded Subtle Medical in 2017 alongside Stanford neuroradiologist Dr. Greg Zaharchuk, and has grown the company to serve 1,000+ scanner installations globally, touching 2.5 million patients annually. Before Subtle Medical, he co-founded Polarr, an AI photo-editing startup used by tens of millions. He has been recognized by Forbes 30 Under 30 (China/APAC, 2018), Fortune 40 Under 40, and Radiology Business 40 Under 40 (2024), and led Subtle Medical to TIME's World's Top HealthTech Companies list in 2025.

- **Role:** CEO and Co-founder at Subtle Medical
- **Organizations:** Subtle Medical, Polarr, Stanford University
- **Nationality:** Chinese-American
- **Education:** Bachelor's in Biomedical Engineering, Tsinghua University, Master's in Electrical Engineering, Stanford University, PhD in Electrical Engineering (minor in Computer Science), Stanford University
- **Known for:** 9 FDA clearances for AI-powered medical imaging products, 30+ issued and pending patents, 45+ peer-reviewed publications

## Career timeline

- **2012** — Graduated from Tsinghua University with a degree in Biomedical Engineering; moved to Stanford for graduate studies
- **2013** — Co-founded Polarr, an AI-powered photo editing startup, alongside Borui Wang and Derek Yan
- **2015** — Stepped back from Polarr to continue PhD at Stanford, focusing on deep learning for medical imaging
- **2017** — Co-founded Subtle Medical with Stanford neuroradiologist Dr. Greg Zaharchuk
- **2018** — Received Forbes 30 Under 30 recognition (China/APAC); won NVIDIA Inception Award; published key research on gadolinium dose reduction via deep learning
- **2019** — Spoke at O'Reilly AI Conference; Subtle Medical received its first FDA clearances; Series A funding raised
- **2023** — Presented MICCAI Industrial Talk on deep learning-based image enhancement and synthesis; spoke at RSNA Conference
- **2024** — SubtleSYNTH received FDA clearance as first approved synthetic data generation AI product; named Radiology Business 40 Under 40; Series B exceeded $30M with Samsung Ventures
- **2025** — Subtle Medical named TIME World's Top HealthTech Company; CE Mark approvals for European expansion; 2.5x annualized US revenue growth; 9 total FDA clearances achieved

## Achievements

- 9 FDA clearances for AI-powered medical imaging products
- 30+ issued and pending patents
- 45+ peer-reviewed publications
- Forbes 30 Under 30 (China/APAC, 2018)
- Fortune 40 Under 40 recognition
- Radiology Business 40 Under 40 (2024)
- NVIDIA Inception Award (2018)
- RSNA Research Award
- ISMRM Merit Awards
- TIME World's Top HealthTech Companies (2025)
- Stanford GenAI Healthcare Award
- Led Subtle Medical to 2.5x annualized US revenue growth in 2025
- Deployed AI on 1,000+ scanner installations worldwide
- AI products touching 2.5 million patients annually
- Raised $44.5M+ in total funding
- Co-founded Polarr, used by tens of millions of users

## Latest updates

- **2025-05** — Subtle Medical named to TIME World's Top HealthTech Companies list
- **2025-04** — Subtle Medical achieved CE Mark approvals for European market expansion
- **2025-03** — Company announced 2.5x annualized US revenue growth and 9 total FDA clearances
- **2025-02** — Advanced GenAI innovation in radiology partnership with NVIDIA announced
- **2024-07** — Samsung Ventures joins Series B, bringing total to $30M+
- **2024-01** — SubtleSYNTH received FDA clearance as first approved AI synthetic data generation product in medical imaging
- **2024-01** — Named to Radiology Business 40 Under 40 class of 2024

## Links

- Website: https://subtlemedical.com
- LinkedIn: https://www.linkedin.com/in/enhao-gong/
- Twitter/X: https://twitter.com/gongenhao

---

Profile page: https://yespress.io/enhao-gong
Published by YesPress — https://yespress.io
Last updated: 2026-05-12